# Vivex Biomedical, Inc.: Form D filings

Vivex Biomedical, Inc., a biotechnology company in Atlanta, GA, filed 5 Form D notices with the SEC between 2013 and 2017. The latest, on May 11, 2017, reports $6.3 million sold of a $7 million offering to 38 investors.

Find out what Vivex Biomedical, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Vivex%20Biomedical%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Vivex%20Biomedical%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvivex-biomedical-inc-1581881)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Vivex%20Biomedical%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Vivex%20Biomedical%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvivex-biomedical-inc-1581881)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Georgia](https://specstream.ai/data/form-d/state/georgia): 1,337 rows, by operating companies, filed since November 1, 2024, $66.85, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/georgia
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 3200 WINDY HILL ROAD, SUITE 1650W, Atlanta, GA, 30339
- Phone: (855) 698-4839
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2012
- Revenue range: $25,000,001 - $100,000,000
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1581881

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 11, 2017 | Amendment | $7,000,000 | $6,280,065 | $719,935 | 38 | Jan 24, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1581881/000158188117000004/0001581881-17-000004-index.htm) |
| Jan 26, 2017 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1581881/000158188117000001/0001581881-17-000001-index.htm) |
| Jan 5, 2016 | New notice | $10,000,000 | $6,609,235 | $3,390,765 | 42 | Dec 23, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1581881/000158188116000002/0001581881-16-000002-index.htm) |
| Sep 16, 2013 | Amendment | $7,241,400 | $7,241,400 | $0 | 51 | Jul 12, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1581881/000158188113000002/0001581881-13-000002-index.htm) |
| Jul 18, 2013 | New notice | $5,500,000 | $2,180,000 | $3,320,000 | 20 | Jul 12, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1581881/000158188113000001/0001581881-13-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Timothy Thomas Ganey, Ph.D. | Executive Officer |  |
| Holly S. Mason | Executive Officer |  |
| John A. McCallum | Director |  |
| Barry Thomas Salzman | Director |  |
| Dr. H Thomas Temple | Executive Officer |  |
| James K. Price | Director |  |
| Tracy S. Anderson | Executive Officer, Director |  |
| J. Miguel Fernandez de Castro | Director |  |
| Timothy S. Taylor | Director |  |
| U. Bertram Ellis, Jr. | Director |  |
| Stuart J Komenski | Executive Officer |  |
| Richard E. Perlman | Director |  |

## Other biotechnology companies in Georgia that filed recently

- [Opus Medical Therapies, LLC](https://specstream.ai/data/form-d/company/opus-medical-therapies-llc-1785788) $485,089 · Sep 22, 2026
- [Airway Therapeutics, Inc.](https://specstream.ai/data/form-d/company/airway-therapeutics-inc-1733867) $43.5 million · Sep 9, 2026
- [FEMASYS INC](https://specstream.ai/data/form-d/company/femasys-inc-1339005) $30 million · Aug 20, 2026

[Every Form D from the week of May 8, 2017](https://specstream.ai/data/form-d/week/2017-05-08) · [All recent filings in Georgia](https://specstream.ai/data/form-d/state/georgia) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Vivex Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).